A World Health Organisation surveillance network tracking leprosy bacilli has detected 8 per cent of samples from new patients in India resistant to rifampicin, a key drug used to treat the infection, sparking concerns about implications for India's leprosy "elimination" goal.
G.S. Mudur
Mar 08, 2018 00:00 IST